Malaria Minute
Malaria Minute | Friday 27th July 2018
The FDA’s approval of GSK’s new malaria drug Tafenoquine (Krintafel) provokes a mixed response and a research team from the ANU and The University of Queensland make a ‘small fragment of human protein’ that kills the microbial parasite that causes malaria.